A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and knee
- 30 September 2000
- journal article
- clinical trial
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 8 (5), 335-342
- https://doi.org/10.1053/joca.1999.0307
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United StatesArthritis & Rheumatism, 1998
- Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society: Results from a workshopOsteoarthritis and Cartilage, 1996
- Guidelines for the medical management of osteoarthritisArthritis & Rheumatism, 1995
- Amelioration of lapine osteoarthritis by treatment with glycosaminoglycan–peptide association complex (Rumalon)Arthritis & Rheumatism, 1991
- A clinical trial of glycosaminoglycan-peptide complex (‘Rumalon’) in patients with osteoarthritis of the kneeCurrent Medical Research and Opinion, 1987
- Indexes of Severity for Osteoarthritis of the Hip and Knee:Validation–Value in Comparison with Other Assessment TestsScandinavian Journal of Rheumatology, 1987
- Criteria for the Classification of Osteoarthritis of the Knee and HipScandinavian Journal of Rheumatology, 1987
- Biochemische Untersuchungen zur Wirkungsweise des GAG-Peptid-Komplex Rumalon®Aktuelle Rheumatologie, 1984
- Stimulation of Protein–Chondroitin Sulfate Synthesis by Normal and Osteoarthritic Articular CartilageArthritis & Rheumatism, 1968
- Radiological Assessment of Osteo-ArthrosisAnnals Of The Rheumatic Diseases, 1957